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This report is submitted by a working group sponsored by the ASMS Measurements and
Standards Committee. The group responded to a 1998 opinion piece dealing with mass
spectrometry in trace analysis (Bethem, R. A.; Boyd, R. K. J. Am. Soc. Mass Spectrom. 1998, 9,
643–648) which proposed that the concept of fitness for purpose addresses the needs of a wide
range of analytical problems. There is a need to define fitness for purpose within the current
context of mass spectrometry and to recommend processes for developing and evaluating
methods according to suitability for a particular purpose. The key element in our proposal is
for the interested parties to define in advance the acceptable degree of measurement
uncertainty and the desired degree of identification confidence. These choices can serve as
guideposts during method development and targets for retrospective evaluation of methods.
A series of more detailed recommendations are derived from basic principles and also from
reviews of current practice. This report highlights some areas where consensus is evident, but
also revealed the need for further work in other areas. The recommendations are aimed
primarily for the laboratory analyst but we hope they will be accessible to the non-scientist as
well. Our goal was to provide a framework that can support informed decisions and foster
discussion of the issues, because ultimately it is the responsibility of the analyst to make
choices, provide supporting data, and interpret results according to scientific principles and
qualified judgment. (J Am Soc Mass Spectrom 2003, 14, 528–541) © 2003 American Society for
Mass Spectrometry
Mass spectrometry is often called upon to ad-dress legal, regulatory, or other societal con-cerns that are outside the realm of academic
inquiry. Such questions may include (but are not lim-
ited to):
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• Is a suspect compound present or not?
• Is a suspect compound present above some decision
point?
• What is the limit at which a method can answer
either of these questions?
A successful outcome—for the analyst as well as for his
or her client—depends on appropriate preparation,
methodical laboratory work, and a defense of the data’s
validity in light of generally-accepted principles.
In 1996 the ASMS sponsored its annual Fall Work-
shop [1] on the theme of “Limits to Confirmation,
Quantitation and Detection” in order to foster discus-
sion of these issues. Many different viewpoints were
presented on such topics as data requirements for
confirming the presence of a suspect compound and for
establishing a method’s limit of quantitation. The con-
ference organizers subsequently published two reports
in the Journal of the ASMS. The first report summarized
the presentations of the invited speakers [2] while the
second report—an opinion piece—assessed the diver-
gence of opinions and attempted to define a logical next
step [3].
After the appearance of the second report in 1998, a
working group was formed under the auspices of the
ASMS Measurements and Standards Committee to con-
tinue this process. The 1996 Workshop revealed that it
was not realistic to pursue a single, universal perfor-
mance standard that, if met, would guarantee success in
any situation. Different applications have different
needs and therefore require different responses from
analysts. However, we believe there is a need to bring
unity to the divergence of opinions within the mass
spectrometry community. By drawing ideas from many
sources, we attempted to craft a generally-applicable
process for conducting analyses in adversarial situations.
[In the adversarial context there is a conflict over the
interpretation of data. The conflict is resolved by choos-
ing one side over another. The quest for scientific truth
may be subordinate to the desire to prevail.]
This report is presented in sections of varying
depths. The recommendations are described in an Ex-
ecutive Summary, which hopefully is appropriate for
both scientists and non-scientists. Numbered endnotes
cite references to publications listed in the Reference
section. Detailed discussions are provided in the text, if
brief, or as appendices (with Roman numerals) if exten-
sive. Some concepts are illustrated in figures.
To make this discussion more accessible, we pro-
vided examples (Appendix I, Examples) of situations
where analysts could make use of our recommenda-
tions. These examples are drawn from a variety of
disciplines and activities. Readers may want to review
these examples and to keep them in mind before
reading further.
Ultimately it is the responsibility of the analyst to
make choices, provide supporting data, and interpret
results according to scientific principles and qualified
judgment. We hope to provide a framework that can
support informed decisions and foster discussion of the
issues. It is appropriate for the ASMS to contribute to
this discussion, because many ASMS members provide,
defend or review data in adversarial situations. Some
recommendations were based on a survey we con-
ducted at the 1999 ASMS Conference (Appendix II,
Survey). Where some issues could not be fully resolved,
we tried to describe the problems and point toward
possible solutions.
Executive Summary of Recommendations
The unifying principles underlying this report are:
• Analysts should use methods which are Fit for
Purpose.
• Analysts should be able to show that their methods
are Fit for Purpose.
Analysts need to work with basic principles of Fitness
for Purpose because in most cases we bear the burden
of defending our methods and choices. No recommen-
dations or guidance from any agency, advisory group,
or professional society can fully remove this burden.
Indeed, our own fitness as experts in our own field is
dependent on familiarity with the issues described in
this report (Appendix III, Purpose).
We advance the following definition:
• Fitness for Purpose means that the uncertainty
inherent in a given method is tolerable given the
needs of the application area.
Figure 1 is a flow chart showing a process for achieving
and demonstrating method fitness. Basically the pro-
cess consists of addressing the most important things
first. Each stage consists of specific investigations of key
factors. Detailed discussions of each stage are listed in
Appendix IV, Detailed Process.
The first stage is a detailed examination of what is at
stake. One should investigate and define the external
factors that influence choices in methodology and re-
porting. The objective of this stage is to define the
analytical purpose in a way that sets targets for accept-
able uncertainty. The concept of acceptable uncertainty is
key to working with these recommendations. The con-
cept can be defined more fully:
• Targets for measurement uncertainty describe how
accurate and precise the measurements need to be.
• Targets for identification confidence describe how
certain one needs to be that the correct analyte has
been identified.
The second stage is to define the method itself. This
process is the conventional method development pro-
cess familiar to all analytical chemists. The work should
be conducted with the acceptable uncertainty range in
mind.
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The third stage is to assess the uncertainty of the
method. There are a variety of possible ways to assess
measurement uncertainty and identification confidence.
However, it is important to recognize that there are two
divergent approaches to assessing uncertainty. These
two approaches are applicable for both quantitative
methods and qualitative methods:
• Empirical or top-down approaches work with data
acquired within the method’s working range and
use a holistic view of method performance.
• Statistical or bottom-up approaches look to differen-
tiate signals from background and consider method
performance as a combination of individual steps.
These two basic approaches apply to either qualitative
or quantitative methods, and may be carried out in
various ways in each case. Analysts must select from a
variety of options to assess analytical uncertainty.
The conclusion of the process is to evaluate whether
the method is acceptable:
• Establishing method fitness consists of showing
that the targets for measurement uncertainty and
identification confidence have been met.
The process may be iterative if the targets cannot be met
initially, in which case the method should be revised
and re-evaluated.
Our group deliberately chose not to write prescrip-
tive recommendations. On the other hand, our inclusive
process enabled us to assess trends within the mass
spectrometry community. Since the 1996 Workshop a
growing number of agencies and bodies worldwide
have codified the standards that are considered appro-
priate within their jurisdiction or discipline for confirm-
ing the presence of suspect compounds (qualitative
analyses). We surveyed draft guidance documents [4]
for common elements that could be considered a set of
core concepts and definitions within the mass spectro-
metry community (Appendix V, Core Concepts).
• Certain confirmation criteria were common to all
surveyed guidance documents:
– Reference standard [all recommendations in this
Report are based on the assumption that a refer-
ence standard is available. The structural identifi-
cation of unknowns is not addressed here] should
be analyzed contemporaneously with unknowns;
– Identification should be based on three or more
diagnostic ions (at nominal mass accuracy).
– Relative abundance matching tolerances should be
used for selected ion monitoring.
– There should be a quality assurance/quality con-
trol program.
– Analytes should be separated by on-line chroma-
tography prior to analysis.
The sets of glossaries examined revealed a number of
terms that could be defined for a particular method, as
well as a few ambiguous terms that should be avoided
or carefully defined. The term Diagnostic Ion was the
only term that appeared in all documents surveyed,
which highlights the importance of this issue (Appen-
dix VI, Diagnostic Value of Data):
• The diagnostic value of selected signals should be
assessed and described.
The lower limit of method performance is usually the
most hotly debated aspect of methods used in adver-
sarial situations. Our recommendations lead to a par-
ticular understanding of method limits:
• A method’s limit is the point where the targets for
acceptable measurement uncertainty or identifica-
tion confidence can no longer be met.
• Given this definition, the empirical or top-down
approach is preferable for describing method limits
in adversarial analyses.
Since the working range of the method is defined as the
range where analytical uncertainty is acceptable, the
Figure 1. Recommended process for achieving fitness for purpose.
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limit of the working range is the point where measure-
ment uncertainty or identification just fails the targets
set in stage 1 (Figure 1). The virtue of this understand-
ing of method limits is that data supporting the validity
of a method are acquired within the working range of
the method. Descriptions of method limits are not based
on analyses outside the method’s true capability, for
example, by measuring the apparent concentration of
background noise (Appendix VII, Method Limits).
There are many areas where analysts must make
important choices in selecting methods. Sometimes an-
alysts must make choices in the absence of clear guid-
ance from clients; such choices should be documented.
There may be an assumption that a “conventional”
analysis is appropriate but such assumptions need to be
examined for method fitness in the given application.
Our basic recommendation for handling these choices is
• All choices that are inherent in the chosen method-
ology should be documented.
Certain choices are especially critical:
• Identification criteria are neither absolute nor arbi-
trary: they arise from the level of identification
confidence that is considered acceptable for a given
application.
• Method limits may be determined according to
either qualitative or quantitative considerations;
the point where identification confidence is unac-
ceptable could be different from the point where
precision and accuracy are unacceptable.
• For qualitative methods, the desired balance be-
tween the acceptable rates of false positives and
false negatives should be described. (Appendix
VIII, Objectives of Qualitative Analyses).
Issues specific to qualitative methodology. The greatest
need for improved clarity concerns qualitative methodol-
ogy, i.e., methods of identification. There is not yet a
generally-accepted manner for describing, either nu-
merically or in prose, the identification confidence
associated with a given method. At present we can
identify several strategies for describing this qualitative
uncertainty, but even these are far from ideal (Appen-
dix IX, Assessing Qualitative Uncertainty).
Figure 2 shows a stepwise proposal for demonstrat-
ing the fitness for purpose of qualitative methods.
Specific steps are outlined according to the stages of our
general recommendations (Figure 1). For certain steps,
the underlined items could benefit from further clarifi-
cation:
• Certain additional resources are still needed in this
area:
– A glossary of terms for expressing the degree of
identification confidence.
– Updated guidelines for the use of exact mass
measurement in qualitative methods.
– Updates on “core confirmation criteria” gleaned
from documents worldwide.
– Links to libraries of mass spectra and information
on library-search algorithms.
– A consensus-based approach to estimating the
total selectivity of a method.
– A bibliography of publications on method valida-
tion.
– A training or qualification process for analysts,
reviewers and experts.
– A bibliography of legal precedents, guidance doc-
uments, and compendia of reference methods.
Finally, the manner of reporting results is critical for
translating technical results to a form desired by the
client. If one assumes the client prefers a simple
YES/NO answer, then the question must be defined
precisely. The first two questions are features of the
technique, and can be addressed objectively. However,
the third question requires an interpretation of data,
and may always contain some degree of subjectivity.
• Were the decision criteria met?
• Was the method capable of meeting the targets for
identification confidence and measurement uncer-
tainty?
• Does the analyst conclude that a suspect analyte is
present above some limit or some concentration?
Figure 2. Demonstrating fitness for purpose of qualitative meth-
ods. Underlined items could benefit from further clarification or
additional resources in the mass spectrometry community.
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We hope this overview of the issues will foster clarity
wherever mass spectrometry is used to support deci-
sion-making in the greater society.
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Appendices
I. Examples
• You work in the central research laboratory of a
chemical manufacturer. One lot of your company’s
product fails to meet a basic QC test. Contamination
of a raw material is suspected, but the certificates of
analysis from your supplier seem in order. You
screen reserve samples of the raw material and
identify a contaminant. On the basis of your results,
your company files suit against the supplier to re-
cover losses due to the contamination. The supplier
disputes your results.
• You are an employee of a contract research organi-
zation. An agrochemical company contracts with
your employer to develop a surveillance method that
will meet the needs of a regulatory agency. You
strictly follow the language of the contract. Halfway
through the project you begin to suspect that the
language of the contract asks your employer to do
something different from what the agency regula-
tions seem to call for.
• While running a routine method for a customer, an
automated software program fails to flag an analyte
that you believe is clearly present in the sample. You
can substantiate your assessment that the analyte is
present by examining the data. However, the custom-
er’s method only allows for automated data process-
ing, not manual processing.
• Your new Standard Operating Procedure for confir-
matory analyses requires an independent review
before any results are acted upon. However, no one
in your Quality Assurance Unit is familiar with mass
spectrometry. How does the QAU receive appropri-
ate training and certification to perform independent
data reviews?
• You work for a regulatory agency. Routine monitor-
ing turns up a compound that might be at a violative
level. You are asked to describe how confident you
are that your measurement exceeds the threshold
level for enforcement action, and how confident you
are that the suspect compound has been identified
correctly. Depending on your answer, the agency
may or may not begin a lengthy legal process.
• You have run a particular method routinely for a
long time, and you know that a certain compound
will either be present in the sample at an easily
detectable level or it will not be present at all. You
find a positive result for the compound at a barely
detectable level.
• A client requires three ions be used for MS confirma-
tion of a set of compounds, but some of the analytes
only give two major ions. Analysis of blanks and
spiked samples indicate that the method consistently
identifies those analytes correctly on the basis of only
two ions. Using only two ions for monitoring, your
analyses of the client’s samples result in identifying
those particular analytes only in matrices from a
certain location.
• You work for a contract laboratory running samples
in a competitive area. Your competitors can do the
analysis for $50/sample, but you can trim your costs
to $40/sample by using a method with less definitive
identification criteria.
• You use a simple mass spectrometric method to
screen a set of samples for a set of target analytes. The
method is fast and cheap because the method is not
very rigorous in its diagnostic power. A few samples
are flagged for follow-up analysis by a more rigorous
and costly confirmatory method. The rigorous
method fails to identify any target analytes in the
samples flagged by the screening method. Your re-
sults are challenged because the two methods gave
conflicting results for the same samples.
II. Survey of Attendees at the 1999 ASMS
Conference
The survey aimed to investigate the form and content of
a resource document that might help analysts deal with
adversarial situations. Questions concerned (1) analyti-
cal purpose, (2) document format, (3) factors that influ-
ence the respondent’s work environment, and (4) the
disciplines, employers and personal opinions of the
respondents. Respondents ranked the importance of
each issue and the potential value of a resource docu-
ment in their setting. Salient results of the survey are
listed below, roughly in order of the clarity or strength
of the responses. This summary is not a formal position of
the Society or its membership.
• Every purpose we listed was considered highly im-
portant to at least some respondents.
• These issues are primarily of concern to analysts in
government or private enterprise, not academia.
Some non-ASMS members are also concerned with
these issues.
• No consensus emerged on most issues; i.e., there
were no issues clearly relevant or critical to every
group. Some issues were of great importance to some
but of little importance to others. The relative impor-
tance of each specific issue varied with the analyst’s
employer or discipline.
• A resource document was perceived to be more
valuable if flexible or innovated methods were
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needed, and less valuable if conventional criteria or
an established precedent were applicable.
• All respondents were subject to some form of over-
sight. Ranked from most to least frequently men-
tioned, these included: Regulatory agencies, peers,
inspectors in QA or GLP programs, internal auditors,
public interest groups, clients, and juries. Every
source of oversight was important to at least some
respondents.
• There were some points of general agreement:
– The Society has the support of analysts in fostering
discussion of this topic.
– The language of a resource document should be
scientifically precise but understandable to non-
scientists.
– The preferred formats for a resource document
included general recommendations, a decision
tree, or a checklist. Prescriptions or a standard
procedure were not favored.
– The resource document was deemed of greatest
value at the inception and conclusion of work (i.e.,
for help in defining the purpose, reporting results,
and defending choices).
– Analysts typically need to minimize time more
than to minimize cost.
• The more important factors were identified as fol-
lows:
– Availability of reference standard.
– Validation of methods before their application.
– Thorough consideration of the issues related to
uncertainty in measurements.
– Ability to modify existing methods and perfor-
mance requirements.
– Demonstration of consistent matrix background,
lack of interference.
– Oversight of regulatory agencies.
• Certain factors were moderately important to ana-
lysts. These included the use of corroborating data,
whether the concentration range was at trace levels
or higher, the perceived threat posed by suspect
compound, and the use of library matching or accu-
rate mass measurements.
The survey respondents ranked certain external issues
(oversight, analyte risk) as less important than many
technical issues. This was in contrast to the opinion of
our working group members. Our view held that all
external issues should be considered before technical
issues, so that method development and application
address the needs of a pre-defined purpose. Our rec-
ommendations are a blend of the survey’s indications
and our group’s views.
III. Purpose
At the 1996 Fall Workshop, M. A. Kaiser advanced the
following definition: “Fitness for purpose refers to the
magnitude of the uncertainty associated with a mea-
surement in relation to the needs of the application
area.” Thompson and Ramsey [5] defined fitness for
purpose as “the property of data produced by a mea-
surement process that enables a user to make techni-
cally correct decisions for a stated purpose.” We felt
that by comparing the magnitude of uncertainty asso-
ciated with a method to the degree of certainty needed
for the application, it might be possible to put this entire
process on an objective basis.
The two principles stated in our Executive Summary
(Analysts should use methods which are Fit for Pur-
pose. Analysts should be able to show that their meth-
ods are Fit for Purpose) correspond in a general way to
the first two of six principles of best practice recom-
mended by a Eurachem working group on the Fitness
for Purpose of Analytical Methods: “Analytical measure-
ments should be made to satisfy an agreed requirement,
i.e., to a defined objective. Analytical measurements
should be made using methods which have been tested
to ensure they are fit for purpose” [6].
There are important benefits to defining analytical
purpose after a complete examination of what is at
stake:
• This process can result in a better definition of the
technical problem.
• A definition of purpose can be used to develop
performance criteria that make sense for the situation
at hand.
• The process of defining method fitness prospectively
(i.e., in advance) draws the interested parties together
in a way that can bring out conflicting expectations or
assumptions. We believe it is preferable to reveal and
resolve such conflicts before the fact, because if
hidden conflicts emerge when analyses are complete,
the value of even rigorous work will be diminished.
In the present era, the business model for analytical
laboratories emphasizes the relationship to the customer
for whom analyses are conducted. However, the notion
of customer can be resolved into several distinct aspects.
Clients use technical results as the basis for a decision.
Patrons pay for analyses. Beneficiaries are those whose
welfare may depend on the decision. The analyses may
be subject to oversight from a variety of internal or
external groups. In a strictly contractual arrangement
between private parties, the client, patron, beneficiary,
and overseer may be the same person or corporation.
However, when government agencies, international
bodies, courts, non-profit organizations, accreditation
bodies, third-party reference laboratories, etc. are in-
volved, the concept of customer can be quite frag-
mented. It is important for analysts to identify and
document the assumptions and expectations of each
interested party when defining analytical purpose. If
there are conflicting interests, it is preferable to address
these early in the process, before laboratory work
begins.
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IV. Detailed Process
First, examine what’s at stake. If the client cannot offer
guidance in the first stage, then document the assump-
tions built into choices made on the client’s behalf.
• Define the analytical problem. Every analytical problem
includes both qualitative and quantitative aspects.
• Evaluate the perceived risk associated with the analyte and
the potential consequences associated with the analytical
result. The effort put into planning needs to be
proportional to the potential impact of the result
more than the technical difficulty. In adversarial
situations, the perceived risk and potential conse-
quences could be quite out of proportion to the
technical complexity. Analysts should prepare for
each possible outcome, not just the preferred out-
come.
• Consider the needs of all interested parties. The interested
parties may include some or all of the following:
Regulatory agencies, peers, inspectors in QA or GLP
programs, internal auditors, public interest groups,
clients, or juries. These parties could be technically
unsophisticated or openly hostile. However, the act
of asking for clarification from people with some-
thing at stake may well increase their understanding
and decrease their hostility. As a final consideration,
it may be necessary to consult with legal advisers
before proceeding.
• Balance the need for thoroughness versus time and re-
sources available. Analytical laboratories may find that
time is more valuable than money, or that funds are
inadequate to address every issue completely. If time
and money do not permit, it may not be possible to
achieve a solution that is technically rigorous in
every aspect.
• Define the acceptable uncertainty. This is the key issue
in establishing method fitness. The analyst and client
should jointly set limits on the precision and accuracy
that are acceptable for measurement purposes, as
well as limits on false identifications that are accept-
able for qualitative purposes.
• Identify the expected concentration range. Certain tasks
can be handled differently if the analyte is suspected
to be present at trace levels (near the method’s lower
limits) or considerably above trace levels.
• Consider the sophistication of the client and report. Re-
porting needs may vary among clients and situations.
Without making any universal recommendations, it
is necessary to agree in advance of what form the
report should take, and how results will be reported.
Next, define the method. This stage comprises conven-
tional method development and validation. These is-
sues have been thoroughly discussed in many prior
publications, and will not be treated in depth here:
• Obtain reference standard.
• Determine if a reference method is required or available.
• Define the needed mass measurement accuracy.
• Characterize the matrix, background, and possible inter-
ferences.
• Establish analyst expertise and proficiency.
• Check system suitability and compliance with SOPs.
• Balance the expected concentration range in the light of
qualitative and quantitative issues.
• Validate the method and/or perform appropriate Quality
Assurance.
• Determine if corroborating data will be used [non-MS
methods or MS libraries].
Then, assess uncertainty. Quantitative uncertainty is
conventionally described in terms of precision and
accuracy. Qualitative uncertainty may be described as
potential rates of false positive and false negative re-
sults, or as some measure of spectral uniqueness or
probability of correctness.
Qualitative analyses aimed at unambiguous identifi-
cation have historically been called confirmation meth-
ods. In qualitative analyses, the rate of false negatives is
the percent of samples known to contain the suspect
analyte that fail to meet the method’s confirmation
criteria. Conversely, the rate of false positives is the
percent of samples known to contain the suspect ana-
lyte that meet the method’s confirmation criteria any-
way.
Various algorithms and data libraries exist for com-
puting spectral uniqueness or the probability that an
identification is correct. Proper use of these measures of
identification confidence depends on grasping the as-
sumptions built into the algorithms, as well as consid-
ering the size and quality of the data library.
V. Core Concepts
Core confirmation criteria. If there is to be a core set of
confirmation criteria and definitions that evolve within
the mass spectrometry community, this core should
appear as elements that are common to all criteria
documents now in force or under development. We
compiled such common elements from a limited survey
of guideline documents, whether in draft or final form
[4]. Common elements were interpreted as the shared
professional judgment of the mass spectrometry com-
munity. Elements that varied among the documents
were considered as areas in which analysts must make
key choices when developing methods that fit their
purpose.
It is critical to realize that no document described its
recommendations as absolute. The regulatory bodies set
firm requirements, but still might allow in-house vari-
ation if supported by justification, validation, and/or
pre-approval. The advisory body offered clear guid-
ance, but would allow customized methods if appropri-
ate scientific expertise, judgment, and review were
applied. Therefore, even when method developers rely
on guidance provided by an agency or advisory group,
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they still have a certain burden of proof to justify their
choices.
Certain criteria appeared in all documents. It is in the
spirit of our working group’s view that these elements
represent the core judgment of the mass spectrometry
community:
• Use of reference standard analyzed contemporane-
ously with unknowns.
• Three or more diagnostic ions (except for exact mass
measurements).
• Use of relative abundance matching tolerances for
selected ion monitoring (SIM).
• Quality assurance/Quality control program.
• On-line chromatography prior to MS analysis.
Although the last two elements are not directly con-
cerned with mass spectrometry, it is clear that quality
management and chromatographic separations are
widely considered critical to the success of analytical
methods used in the adversarial context.
The following elements appeared in four of the five
documents, and should be seriously considered when
developing confirmatory methods:
• Signal-to-noise minimum of 3:1.
• Characterization of performance at lower concentra-
tion limit.
• Method validation.
• Demonstration of method specificity (absence of in-
terferences) through analysis of negative controls.
• Equivalence of precursor-product ion pair to two
diagnostic ions.
• Choice of scan function, ionization technique.
The use of a negative control (i.e., blank matrix) is very
important for quality assurance and validation pur-
poses. The lack of bona fide control matrix could act to
reduce identification confidence and increase the limit
of quantitation. A similar or surrogate matrix, or even a
sample which shows no analyte signals, is preferable to
using no control matrix at all.
Variable confirmation criteria. At the other extreme,
there was considerable variation in the acceptance win-
dows (matching ranges) for acceptable relative abun-
dances in SIM, when using electron ionization. The
matching ranges were different in virtually every case.
Clearly there is no generally-accepted approach to
relative-abundance matching in SIM, although there is a
moderate degree of conformity among the various
approaches (Figure 3). The matching tolerances defined
by various groups diverge because they must oversim-
plify what is actually a complex situation. De Boer et al.
showed that simple matching tolerances (as in Figure 3)
do not reflect the reality of abundance variation for
certain drugs analyzed repeatedly by GC/MS [7]. Stein
showed that ion abundance variability is best modeled
by the square root of abundance multiplied by a com-
pound-specific factor [8]. Consequently, it may not be
fruitful to put exhaustive attention on matching toler-
ance selection, other than to use matching criteria that
are not dramatically different than the ranges evident in
Figure 3.
Core definitions. We compiled a list of terms from the
glossaries included in five draft guideline documents.
There was not much overlap among terms defined in
Figure 3. Comparison of abundance matching tolerances, EI-GC/MS. The legend indicates which
document listed under reference [4] recommends each particular matching tolerance.
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various glossaries. The only term that was defined in
every document was diagnostic ion (or, the alternative
terms structurally-specific or structurally-significant).
The composite glossary was rich with key terms and
concepts that could be addressed in a detailed descrip-
tion of a confirmatory method. These included: Analyte
(or target compound), blank matrix (or negative con-
trol), carryover, failure to confirm, limit of confirmation
(or limit of identification), noise characteristics, peak
resolution, presence, qualifier ion, quantitation ion, rate
of false negatives (or  error), rate of false positives (or
 error), reference material (or standard), reference
method, screening method, specificity, suitability, trace-
able (or certified), validation, violative result.
Variable definitions. In the draft documents examined,
confirmation was used to mean either verification of a
prior test or verification of the presence of a suspect
compound. This ambiguity reflects a historical trend.
Mass spectrometry was first used non-routinely to
“confirm” prior results from less specific detectors. As
capable and user-friendly instruments proliferated, con-
firmation was applied to firmly identifying the presence
of target analytes, with mass spectrometric data primar-
ily standing alone.
There was a range of definitions for detection. There
are several critical problems with this term that make it
undesirable in adversarial analyses. Detection is under-
stood by non-scientists as an identification with high
confidence. However, detection is also used to mean an
event in which a signal can be differentiated from noise.
This mode has the lowest qualitative confidence possi-
ble, because a single signal at this level has little
diagnostic value.
It is in the spirit of our working group’s view that
detection is a term that should be avoided, in favor of
some definition of identification or confirmation crite-
ria. Identification with the utmost certainty is better
described as confirmation, where multi-ion identifica-
tion criteria are fully met and each diagnostic signal is
fully distinguished from noise.
Certain terms are understood differently between
scientists and non-scientists. Furthermore, scientists
from different disciplines may not use the same term in
the same way. These terms include (in addition to
detection and confirmation) absence, confidence, negative,
positive, probability, screening, and uncertainty. Definitions
should be spelled out clearly if terms with multiple
meanings are used. It has been recommended that the
terms selectivity be used to express a degree of confi-
dence, while specificity applies only to a quality of
exclusiveness or uniqueness. That is, if a method is
selective enough, it can become specific [9].
VI. Diagnostic Value of Data
Diagnostic ions indicate the presence of the target
compound. As more diagnostic data is acquired, the
confidence in the identification increases. It is recom-
mended that quantitative methods also include identi-
fication criteria, because quantitation typically makes
use of only a single data channel. Furthermore, the
diagnostic power of conventional quantitative methods
are frequently based on assumptions that translate to
95% confidence (1 in 20 chance of false identification).
Analysts must determine if this qualitative confidence
is adequate. Some purposes (e.g., confirmation) may
require considerably higher confidence in the identifi-
cation, and this can be accomplished by using multiple
diagnostic ions to increase selectivity. The diagnostic
information in a mass spectrum is essentially a compos-
ite of various elements. Depending on the analyst or
application, the following elements may be combined in
various weightings:
• m/z Values. Each observed ion may be indicative of a
specific structure.
• Exact mass. For lower-mass ions (roughly 500 Da)
measured with sufficient accuracy (e.g., 5 ppm),
unique elemental formulae may be indicated.
• Mass differences. For two observed ions, the difference
may indicate loss of a specific moeity. This mass
difference may be non-specific (e.g., loss of 18 Da) or
unique, depending on value.
• MS/MS transition. One ion is shown to be a discrete
fragment of another ion.
• Abundance ratios. Ion abundance ratios are a function
of unique ion chemistry, and are useful because their
values can be compared and/or treated statistically.
• Isotopes. Some abundance ratios may indicate pres-
ence of specific elements.
• Molecular ion. Presence of certain adduct ions may
give strong support for nominal molecular weight.
• Spectral pattern. The entire mass spectrum can be
treated mathematically as a unique pattern, without
regard to structural interpretation as above.
VII. Method Limits
Method limits define the transition between acceptable
and unacceptable performance. The distinctions be-
tween bottom-up and top-down approaches were de-
scribed previously. The strengths and weaknesses of
each approach can be evaluated in various situations.
The top-down approach is more consistent with the
Working Group’s recommendations, because accept-
ability criteria are defined in the first stage of method
development, and then data are acquired which indi-
cate a point where these acceptability criteria can no
longer be met.
In the bottom-up approach, a limit of detection corre-
sponds to the minimum signal that can be differentiated
from noise. Unfortunately, this approach makes an
assumption that the signal is derived from the target
analyte, because in mass spectrometry there is little
diagnostic value in such a signal. This approach is not
recommended, especially in adversarial circumstances.
In the top-down approach, the limit of “detection”
corresponds to the lowest level at which the weakest
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diagnostic signal is still evident. The pre-determined
identification criteria are met, so the predetermined
level of acceptable qualitative confidence is met. [Fur-
thermore, due to ambiguity in the meaning of detection,
it is preferable to define qualitative limits in other
terms.] Alternatively, a qualitative limit can be defined
as the point where the rate of false positives is unac-
ceptable, or where the rate of false negatives is unac-
ceptable. In each of these empirical approaches the limit
is keyed to a target determined during the initial
examination of what’s at stake.
In the bottom-up approach, a limit of quantitation
corresponds to the minimum signal that can be differ-
entiated from noise at some quantifiable level of confi-
dence. In the top-down approach, a limit of quantitation
corresponds to the level in the working range below
which the precision and accuracy are no longer accept-
able. The latter viewpoint ties the method’s LOQ to the
initial examination of “what’s at stake” and thus is quite
in line with our recommendations. Futhermore, this
level can be established with true signals that fall within
the working range of the method. Extrapolations based
on noise levels or signals with little diagnostic value are
not required.
VIII. Various Objectives for Qualitative Analyses
There are two clearly distinct and opposed qualitative
analytical purposes—enforcement and risk assessment.
Each is characterized by the need to avoid false out-
comes, either by minimizing false positives (enforce-
ment) or false negatives (risk assessment). For example,
a false positive outcome could result in falsely accusing
an innocent person. On the other hand, mass spectro-
metry is often used to search for the presence of a
potentially dangerous substance. In such cases, it is
critical to not overlook the presence of a “bad actor”.
These cases call for methods with a low rate of false
negative outcomes. The need for such methods fre-
quently arises from risk assessment, such as in health and
environmental monitoring.
There are other analytical purposes that are interme-
diate, or somewhat more tolerant of false outcomes.
Frequently these cases result from dosing experiments,
where a known substance is added to a system, and the
compound (or a metabolite or degradant) is identified
elsewhere in the system. This prior knowledge about
the system can contribute to acceptance of less rigorous
confirmation criteria or intermediate degrees of confi-
dence. In other cases maximum rigor may not be
considered necessary. For example, Geerdink et al. have
described a form of identification with intermediate
confidence as an “indication” [10].
These objectives can be compared by constructing
a distribution function. A given method and a set of
confirmation criteria can be applied to blank matrices
fortified with various amounts of analyte and a plot
can be created showing the percent of samples meet-
ing criteria as a function of concentration. At very
high concentrations the method will virtually always
give a positive outcome. At very low concentrations
there will virtually never be a positive outcome.
There will always be some transition zone, or a range
of uncertainty, within which the method may give
either outcome for repeat analyses of the same sam-
ple. This is an undesirable situation, especially be-
cause the unsophisticated client or layperson may
assume that methods always return a negative result
below some limit, and a positive result at or above the
same value.
Figure 4 compares the rate of false positives among
methods with various objectives. The area above the
curve and to the right represents the percent rate of
false positives for a given set of identification criteria.
Risk assessment methods might tolerate up to a
modest rate of false positives (perhaps 1 in 20 is
reasonable in this case), but enforcement methods
require a far smaller rate of false positives. Dosing
methods are intermediate, since other information
may be used in addition to the mass spectra.
Mass spectrometry may also be used for screening,
although this may be less cost-effective than other
techniques. Screening methods are designed to have a
very low rate of false negatives, to remove true nega-
tives from the sample stream submitted for confirma-
tion (to improve efficiency and reduce cost). The rate of
false positives for a screening method may be quite
high. Therefore, screening methods do not provide
substantive information about what might be present in
a sample. Screens should be part of a multistep process,
combined with a follow-up method with a low rate of
false positives.
IX. Assessing Qualitative Uncertainty
Numerical expressions of identification confidence. Quali-
tative uncertainty may be expressed as potential rates of
false positives and false negatives. It is also possible to
describe qualitative uncertainty through a numerical
expression of spectral uniqueness or probability of
Figure 4. Comparison of various objectives for qualitative meth-
ods. This scheme demonstrates the relative rates of false positives
for various purposes. The solid line is extrapolated from experi-
mental data. The diagram is not necessarily to scale.
537J Am Soc Mass Spectrom 2003, 14, 528–541 ESTABLISHING THE FITNESS FOR PURPOSE OF MS METHODS
correct identification. However, these numerical expres-
sions require a sufficiently large and appropriately
chosen library of mass spectra, because uniqueness
values can only be calculated in relation to such a
library. For electron ionization, such libraries exist, but
libraries of standard MS/MS spectra or spectra ac-
quired by LC/MS with atmospheric pressure ionization
have not been compiled to the same degree. As a result,
there is less basis for generally-acceptable confirmation
criteria in MS/MS or LC/MS. Therefore the burden of
proof is greater on analysts who would use MS/MS or
LC/MS instead of EI-MS methods in adversarial situa-
tions. On the other hand, library-searching can be a
reasonable means to exclude possible incorrect identi-
fications.
Our recommendations call for the selected confirma-
tion criteria to lead to an acceptable degree of identifi-
cation confidence. It is conventional in mass spectro-
metry to describe identification confidence in terms of
predicted rates of false positives and/or false negatives.
However, there are considerable challenges in showing
that this has been achieved in practice. Nevertheless, it
is important to provide data in support of the claims for
identification confidence. There are auxiliary benefits to
an approach to method fitness based on assessment of
analytical uncertainty. In 1993 the U.S. Supreme Court
clarified the Federal Rules of Evidence specifying what
counts in court as science. In Daubert versus Merrell Dow
Pharmaceuticals, the court said that a technique or meth-
odology qualifies as science only if it can be tested, is
subject to peer review, possesses known rates of error,
and is generally accepted as science [11].
Data linking a set of confirmation criteria with a
claimed rate of false negative outcomes are readily
obtained, as follows. Replicate analyses of standards or
fortified samples provide relative abundances from
multiple diagnostic ions. Statistical analysis of the rela-
tive abundance data yields the mean and standard
deviation for each ion. Analysts may define an abun-
dance matching range that achieves a specified confi-
dence limit. For example, a 95% confirmation rate is
achieved with an abundance matching range 2 stan-
dard deviations about each abundance mean. The pre-
dicted false negative rate is then 5% or 1 in 20. De Boer
et al. provide a very complete example of this approach
applied to a GC/MS analysis of veterinary drugs [7].
Data linking a set of criteria with a claimed rate of
false positives is critically important in supporting data
used for enforcement purposes. There are several pos-
sible strategies:
• Interference testing. In theory, exhaustive analysis of
blank matrices and similar compounds demonstrates
the inability of the method to misidentify endoge-
nous or exogenous interferences, respectively.
• Validation. Conventional method validation yields
empirical evidence of performance.
• Library-searching. A numerical measure of spectral
uniqueness can be calculated by comparison to a
large and appropriate library of mass spectra, if one
is available.
• Selectivity scoring. An overall confidence level of a
given method can be compiled from the estimated
selectivity of all steps. Each step of the analysis has
some degree of resolving power, including extrac-
tion, clean-up, chromatography, and separation by
mass through one or more stages. This resolving
power is cumulative, and in theory can become quite
high. Some steps are widely recognized as contribu-
tors to high selectivity, such as monitoring multiple
diagnostic ions, applying limits on abundance ratios,
and using good chromatography to separate matrix
components from target analytes.
As alternatives to these approaches, analysts have his-
torically fallen back on the following strategies to sup-
port their conclusions:
• Qualified professional judgment. If analysts are suffi-
ciently trained, experienced or knowledgeable in the
field, their judgment may be considered reliable to
decide that confirmation has been achieved.
• Independent expert review. An independent audit by a
qualified reviewer may establish the acceptability of
the data.
• Generally-recognized precedent. There may have been a
similar case in the past in which the method or data
quality was found acceptable.
These three strategies are dependent on interpretation
of qualitative data, rather than a strict numeric proce-
dure to draw a conclusion.
• Best practice. There is a tendency to assume that a
confirmation is acceptable if it uses the best mass
spectrometer and method we have available at the
time. Within the framework of our discussion, this is
not an advisable strategy. Establishing fitness for
purpose should not be reduced to accepting what-
ever data are already at hand.
Interpreting qualitative data for utmost certainty. Expert
judgment is as hard to define as qualitative uncertainty.
We hope that one’s expertise will be based on familiar-
ity with adversarial analyses through reports like this
one. Our recommendation is to be aware of the
strengths and weaknesses of various strategies because
many or all of them may be combined to defend a
method’s validity.
Suspect compounds are identified by comparing
data from a reference standard with those of a sample
acquired using the same method. If the data can be
shown to be the same, within some degree of confi-
dence, signals from the unknown can be said to arise
from the presence of the suspect compound. This is the
Null Hypothesis of statistics, meaning that the differ-
ence between the two data sets can be considered null.
The Alternative Hypothesis states that the Null Hy-
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pothesis is incorrect, i.e., the two data sets are statisti-
cally different from one another. From the analytical
chemistry standpoint, the Null Hypothesis means that
the suspect compound can be confirmed as present,
while the Alternative Hypothesis means the suspect
compound cannot be confirmed as present. This is not
the same as proving the compound is absent; one can
only prove it is not present above the limit of confirma-
tion.
Neither viewpoint enables one to absolutely prove
that a suspect compound is present. In statistics, the
Null Hypothesis can never be proved. The closest
approach is to fail to disprove the Alternative Hypoth-
esis. In analytical chemistry, one can never absolutely
prove that the signals detected from the unknown are
due to the suspect compound, because there will always
be some chance (perhaps very remote) that the signals
have arisen from some hitherto unknown compound or
phenomenon. Science does not offer a technical means
of proving absolutely, beyond all possible doubt, that a
suspect compound is present.
It is necessary to address qualitative uncertainty in
order to show that qualitative methods are fit for
purpose. The Null Hypothesis is reasonable if the two
data sets are the same within some degree of confi-
dence. A suspect compound can be considered con-
firmed if the criteria are drawn so the possibility of
error is small enough to meet the needs of the analysis.
If the analyst or reviewer concludes on the basis of
such data that a suspect compound is absolutely present,
this conclusion is an interpretation and not a feature of
the method or data. Interpretations are a matter of
debate. Our recommendation in this regard is to not to
make too great a leap from the data. Shellow asserts
that any subjectivity on the part of the analyst’s inter-
pretation of the results is a potential basis for rejecting
scientific testimony [12]. The defense may raise a rea-
sonable doubt if it can be shown that the analyst
overstated the objective basis for confidence in the
identification. This might arise from making an “abso-
lute” identification on the basis of a weak library-match
or using data from highly variable or non-specific ions.
Approaches to assessing identification confidence. Analyti-
cal uncertainty may be assessed either in a holistic
manner (empirical or top-down) or as an accumulation
of individual steps (statistical, or bottom-up). The ap-
proaches differ, but each can be used to support a
method’s fitness for purpose.
In the bottom-up approach, each step of a method
contributes to overall specificity. This approach yields
the “selectivity index” advocated by Stephany and van
Ginkel in several papers [13–16]. It can be a basis for
comparing the resolving power of various detection
schemes, and for allowing different confirmation crite-
ria depending on detection technology. This approach
is the underlying principle behind a recently-proposed
system of Identification Points for confirmatory analysis
[17]. In principle this is reasonable, but assigning a
value for Selectivity Index of a given method requires
assumptions, or else a considerable effort to build a
consensus estimate. Figures 2, 5, and 6 are inspired by
the Selectivity Index concept. In the absence of any
other objective measure of identification confidence,
this approach is always available, although it is neces-
sarily imprecise. There has been at least one attempt to
compare various methodologies on a consensus-basis,
as is suggested in Figure 5 [14].
Figure 5. Towards consensus selectivity indices. The scheme
attempts to illustrate two inter-related points: (a) That a consensus
of experienced analysts might consider individual steps of various
methods to possess comparable selectivity (reference [14]); (b) that
the cumulative selectivity of multiple steps in a single method
might be described with Selectivity Indices (references [14–16]) or
Identification Points (reference [17]).
Figure 6. Toward a lexicon for expressing identification confi-
dence. The assignment of a numeric scale to these terms is not yet
possible. However, the selectivity index of a screening method
could be in single digits, while that of a method possessing
“utmost certainty” could be some orders of magnitude.
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In the top-down approach, empirical data is used to
demonstrate acceptable identification confidence. Blank
matrices are fortified from well below the predicted
limit to well above it. The percent of such samples (true
positives) found positive is plotted as a function of
concentration to create a distribution function (in Figure
3, the heavy line). The selection of diagnostic signals
determines the exact location of the transition zone. The
chosen set of confirmation criteria need to have an
acceptable diagnostic power for the target compound. It
is also necessary to refer to the target level for full
performance described in stage 1 of method develop-
ment. If the acceptable rate of false positives is achieved
at a concentration lower than the target level, Fitness for
Purpose has been demonstrated empirically.
Another empirical approach to assessing identifica-
tion confidence was described by Sphon in 1978, in a
seminal publication that predates most other discus-
sions of method fitness. When three ions from the EI
spectrum of diethylstilbestrol (DES) were used to search
a library of 30,000 spectra, and abundance criteria were
applied to those ions, the only matching spectrum was
that of DES [18].
X. Measurement Uncertainty
In the bottom-up approach to measurement uncer-
tainty, total method error is calculated by propagating
uncertainty through each step of the method. This calls
for a thorough theoretical review of the method, but
ultimately may not account for all of the experimental
error. In the top-down approach, the method’s preci-
sion and accuracy are determined experimentally by
replicate analyses of true positives. These data result
from a conventional method validation. A working
range is determined according to conventional proce-
dures for precision and accuracy.
Assessing quantitative uncertainty at the lower limit. Quan-
titative analytical uncertainty has been closely exam-
ined over the years. These examinations depend on
constructing a theoretical distribution function. Without
some model for the distribution functions, quantitative
uncertainty cannot be calculated. The distribution func-
tion could be defined by repetitive measurements of
samples where the analyte is either absent (case 1),
present at the detection limit (case 2), or present at some
quantitation limit (case 3).
The classical “detection limit” is based on repetitive
measurements of the background signals when analyte
is absent. Statistical theory based on an assumed normal
(Gaussian) distribution holds that the mean plus some
multiple k of the standard deviation gives the detection
limit, and k defines the confidence level that a signal has
been differentiated from noise. For example, k 2 gives
95% confidence, k  3 gives 99% confidence, etc.
These confidence levels translate to the probability that
a given signal has been differentiated from noise
One may assume that analyte is present at the level
equivalent to this limit of detection. However, to calcu-
late the distribution functions for this or the first case, it
would be necessary to obtain values for measurements
below the detection limit or below zero. This paradox
creates practical problems in determining what repre-
sents a true signal. As an alternative, one may assume
that the analyte is present at the quantitative limit
determined from one of the first two cases. In this
scheme the quantitation limit corresponds to k  6, so
that the confidence level (based on k  3) addresses
whether a true signal has been detected. There is a
defined confidence that the measurement is above the
detection limit, and the distribution function is defined
with true signals. Our recommendations are that the
uncertainty at the lower limit is better found by extrap-
olation from the working range, not by measurements
at or below the lower limit.
Various assumptions about detection limits define
two regions of false outcomes. The -error defines false
positive measurements, where the found value is above
the limit although analyte was not present. The -error
defines false negative measurements, where the mea-
surement was below the limit although analyte was
present.
Assessing quantitative uncertainty at the lower limit
calls for defining the distribution functions with true
signals, along with an explicit understanding of k that is
fit for the purpose. Our recommendations on method
fitness would hold that limits are determined by (1)
agreeing on a given uncertainty target; (2) choosing the
appropriate k value for that uncertainty target; (3)
defining the distribution function with true signals; (4)
setting the limit at a value corresponding to a predeter-
mined level of uncertainty.
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